Prolactin Role in COVID-19 and Its Association with the Underlying Inflammatory Response
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252211905 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Eleni Polyzou und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Patras, 26504 Rio, Greece. Hauptthemen laut MEDLINE: COVID-19, Prolactin, Cytokines, Biomarkers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The COVID-19 pandemic has prompted interest in identifying reliable biomarkers to predict disease severity and guide clinical decisions. Prolactin (PRL), a hormone traditionally associated with lactation, has gained attention for its role in immune modulation. This study aimed to assess PRL as a biomarker for disease severity in COVID-19. A prospective cohort of 142 patients with moderate to severe COVID-19, defined as a WHO-CPS 5 or 6, was recruited from the University General Hospital of Patras. Baseline PRL levels were measured using an electrochemiluminescence immunoassay, and serum cytokines, including IL-1β, IL-6, IL-8, IL-10, IL-12p70, and TNF-α, were quantified through flow cytometry. Clinical outcomes, including mortality and the need for invasive mechanical ventilation (IMV), were recorded. Results indicated that PRL levels were significantly higher in female patients (12.95 ng/mL vs. 9.40 ng/mL, p < 0.001) but they did not correlate with key severity indices such as CCI, SOFA score upon admission or inflammatory markers. No significant associations between baseline PRL levels, cytokine concentrations, and clinical outcomes in COVID-19 were noted. Our findings suggest that PRL may lack prognostic reliability for disease severity compared to more established predictive markers and that its role in the immune response remains uncertain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Patras, 26504 Rio, Greece.
- Department of Internal Medicine, University General Hospital of Patras, 26504 Rio, Greece.
- Division of Endocrinology, Department of Internal Medicine, University General Hospital of Patras, 26504 Rio, Greece.
- Immunology Laboratory, 251 Hellenic Air Force General Hospital, 11525 Athens, Greece.
- Division of Infectious Diseases, Department of Internal Medicine, University General Hospital, 26504 Patras, Greece.
ORCID-Profile: Georgios Schinas, Anne-Lise de Lastic, Athanasia Mouzaki, Karolina Akinosoglou
Zitieren
APA
Polyzou, E., Schinas, G., Bountouris, P., Georgakopoulou, D., de Lastic, A. L., Parthymou, A., Gogos, C., Kyriazopoulou, V., Mouzaki, A., Theodoropoulou, A., & Akinosoglou, K. (2024). Prolactin Role in COVID-19 and Its Association with the Underlying Inflammatory Response. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211905
Vancouver
Polyzou E, Schinas G, Bountouris P, Georgakopoulou D, de Lastic AL, Parthymou A, et al. Prolactin Role in COVID-19 and Its Association with the Underlying Inflammatory Response. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211905
BibTeX
@article{Polyzou2024,
author = {Polyzou, Eleni and Schinas, Georgios and Bountouris, Panagiotis and Georgakopoulou, Dimitra and de Lastic, Anne-Lise and Parthymou, Anastasia and Gogos, Charalambos and Kyriazopoulou, Venetsana and Mouzaki, Athanasia and Theodoropoulou, Anastasia and Akinosoglou, Karolina},
title = {Prolactin Role in COVID-19 and Its Association with the Underlying Inflammatory Response},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252211905}
}
EUVIMED